The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1397
ISSUE 1397
August 20, 2012
Issue 1397
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Ezogabine (Potiga) for Epilepsy
August 20, 2012 (Issue: 1397)
The FDA has approved ezogabine (ee-ZOE-ga-been;
Potiga – GSK/Valeant) for oral adjunctive treatment of
partial-onset seizures in adults. Ezogabine is available
in Europe as retigabine (Trobalt).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.